A Trial Comparing the Pharmacodynamics and Pharmacokinetics of BC Combo THDB0207 and Lantus and Humalog in Subjects With Type 1 Diabetes
Latest Information Update: 09 Mar 2024
At a glance
- Drugs Insulin glargine/insulin lispro (Primary) ; Insulin glargine; Insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Adocia
Most Recent Events
- 14 Sep 2023 Status changed from recruiting to completed.
- 17 May 2022 New trial record
- 13 May 2022 Status changed from not yet recruiting to recruiting.